GENES OF CAROTENOID BIOSYNTHESIS AND METABOLISM AND A SYSTEM FOR SCREENING FOR SUCH GENES

Abstract: The present invention also describes the DNA sequence for eukaryotic genes encoding epsilon cyclase, isopentenyl pyrophosphate isomerase and beta -carotene hydroxylase as well as vectors containing the same and hosts transformed with said vectors. The present invention provides methods for controlling the ratio of various carotenoids in a host and for the production of novel carotenoid pigments. The present invention also provides a method for screeing for eukaryotic genes encoding carotenoid biosynthesis.

Description: TITLE OF THE INVENTION GENES OF CAROTENOID BIOSYNTHESIS AND METABOLISM AND A SYSTEM FOR SCREENING FOR SUCH GENES BACKGROUND OF THE INVENTION Field of the Invention The present invention describes the DNA sequence for eukaryotic genes encoding e cyclase, isopentenyl pyrophosphate isomerase (IPP) and β-carotene hydroxylase as well as vectors containing the same and hosts transformed with said vectors. The present invention also provides a method for augmenting the accumulation of carotenoids and production of novel and rare carotenoids. The present invention provides methods for controlling the ratio of various carotenoids in a host. Additionally, the present invention provides a method for screening for eukaryotic genes encoding enzymes of carotenoid biosynthesis and metabolism. Discussion of the Background Carotenoid pigments with cyclic endgroups are essential components of the photosynthetic apparatus in oxygenic photosynthetic organisms (e.g., cyanobacteria, algae and plants; Goodwin, 1980). The symmetrical bicyclic yellow carotenoid pigment S-carotene (or, in rare cases, the asymmetrical bicyclic α-carotene) is intimately associated with the photosynthetic reaction centers and plays a vital role in protecting against potentially lethal photooxidative damage (Koyama, 1991) . 0-carotene and other carotenoids derived from it or from α-carotene also serve as light- harvesting pigments (Siefermann-Harms, 1987) , are involved in the thermal dissipation of excess light energy captured by the light-harvesting antenna (Demmig-Ada s & Adams, 1992) , provide substrate for the biosynthesis of the plant growth regulator abscisic acid (Rock & Zeevaart, 1991; Parry & Horgan, 1991) , and are precursors of vitamin A in human and animal diets (Krinsky, 1987) . Plants also exploit carotenoids as coloring agents in flowers and fruits to attract pollinators and agents of seed dispersal (Goodwin, 1980) . The color provided by carotenoids is also of agronomic value in a number of important crops. Carotenoids are currently harvested from plants for use as pigments in food and feed. The probable pathway for formation of cyclic carotenoids in plants, algae and cyanobacteria is illustrated in Figure 1. Two types of cyclic endgroups are commonly found in higher plant carotenoids, these are referred to as the β and e cyclic endgroups (Fig. 3.; the acyclic endgroup is referred to as the ■ i or psi endgroup) . These cyclic endgroups differ only in the position of the double bond in the ring. Carotenoids with two β rings are ubiquitous, and those with one β and one e ring are common, but carotenoids with two e rings are rarely detected. β-Carotene (Fig. 1) has two β endgroups and is a symmetrical compound that is the precursor of a number of other important plant carotenoids such as zeaxanthin and violaxanthin (Fig. 2) . Carotenoid enzymes have previously been isolated from a variety of sources including bacteria (Armstrong et al. , 1989, Mol. Gen. Genet. 216, 254-268; Misawa et al., 1990, J. Bacteriol., 172, 6704-12), fungi (Schmidhauser et al., 1990, Mol. Cell. Biol. 10, 5064-70), cyanobacteria (Chamovitz et al., 1990, Z. Naturforsch, 45c, 482-86) and higher plants (Bartley et al., Proc. Natl. Acad. Sci USA 88, 6532-36; Martinez-Ferez & Vioque, 1992, Plant Mol. Biol. 18, 981-83). Many of the isolated enzymes show a great diversity in function and inhibitory properties between sources. For example, phytoene desaturases from Synechococcus and higher plants carry out a two-step desaturation to yield ^"-carotene as a reaction product; whereas the same enzyme from Erwinia introduces four double bonds forming lycopene. Similarity of the amino acid sequences are very low for bacterial versus plant enzymes. Therefore, even with a gene in hand from one source, it is difficult to screen for a gene with similar function in another source. In particular, the sequence similarity between prokaryotic and eukaryotic genes is quite low. Further, the mechanism of gene expression in prokaryotes and eukaryotes appears to differ sufficiently such that one can not expect that an isolated eukaryotic gene will be properly expressed in a prokaryotic host. The difficulties in isolating related genes is exemplified by recent efforts to isolated the enzyme which catalyzes the formation of 0-carotene from the acyclic precursor lycopene. Although this enzyme had been isolated in a prokaryote, it had not been isolated from any photosynthetic organism nor had the corresponding genes been identified and sequenced or the cofactor requirements established. The isolation and characterization of the enzyme catalyzing formation of 0-carotene in the cyanobacterium Synechococcus PCC7942 was described by the present inventors and others (Cunningham et al., 1993 and 1994). The need remains for the isolation of eukaryotic genes involved in the carotenoid biosynthetic pathway, including a gene encoding an € cyclase, IPP isomerase and 0-carotene hydroxylase. There remains a need for methods to enhance the production of carotenoids. There also remains a need in the art for methods for screening for eukaryotic genes encoding enzymes of carotenoid biosynthesis and metabolism. SUMMARY OF THE INVENTION Accordingly, a first object of this invention is to provide isolated eukaryotic genes which encode enzymes involved in carotenoid biosynthesis; in particular, e cyclase, IPP isomerase and / 3-carotene hydroxylase. A second object of this invention is to provide eukaryotic genes which encode enzymes which produce novel carotenoids. A third object of the present invention is to provide vectors containing said genes. A fourth object of the present invention is to provide hosts transformed with said vectors. Another object of the present invention is to provide hosts which accumulates novel or rare carotenoids or which overexpress known carotenoids. Another object of the present invention is to provide hosts with inhibited carotenoid production. Another object of this invention is to secure the expression of eukaryotic carotenoid-related genes in a recombinant prokaryotic host. A final object of the present invention is to provide a method for screening for eukaryotic genes which encode enzymes involved in carotenoid biosynthesis and metabolism. These and other objects of the present invention have been realized by the present inventors as described below. BRIEF DESCRIPTION OF THE DRAWINGS A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein: Figure 1 is a schematic representation of the pathway of β-carotene biosynthesis in cyanobacteria, algae and plants. The enzymes catalyzing various steps are indicated at the left. Target sites of the bleaching herbicides NFZ and MPTA are also indicated at the left. Abbreviations: DMAPP, dimethylallyl pyrophosphate; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; GPP, geranyl pyrophosphate; IPP, isopentenyl pyrophosphate; LCY, lycopene cyclase; MVA, mevalonic acid; MPTA, 2-(4- methylphenoxy)triethylamine hydrochloride; NFZ, norflurazon; PDS, phytoene desaturase; PSY, phytoene synthase; ZDS, ζ- carotene desaturase; PPPP, prephytoene pyrophosphate. Figure 2 depicts possible routes of synthesis of cyclic carotenoids and common plant and algal xanthophylls (oxycarotenolds) from neurosporene. Demonstrated activities of the β- and e- cyclase enzymes of A . thaliana are indicated by bold arrows labelled with β or e respectively. A bar below the arrow leading to e-carotene indicates that the enzymatic activity was examined but no product was detected. The steps marked by an arrow with a dotted line have not been specifically examined. Conventional numbering of the carbon atoms is given for neurosporene and α-carotene. Inverted triangles (T) mark positions of the double bonds introduced as a consequence of the desaturation reactions. Figure 3 depicts the carotene endgroups which are found in plants. Figure 4 is a DNA sequence and the predicted amino acid sequence of e cyclase isolated from A . thaliana (SEQ ID NOS: 1 and 2) . These sequences were deposited under Genbank accession number U50738. This cDNA is incorporated into the plasmid pATeps. Figure 5 is a DNA sequence encoding the / 3-carotene hydroxylase isolated from A. thaliana (SEQ ID NO: 3) . This cDNA is incorporated into the plasmid pATOHB. Figure 6 is an alignment of the predicted amino acid sequences of A . thaliana 3-carotene hydroxylase (SEQ ID NO: 4) with the bacterial enzymes from Alicalgenes sp. (SEQ ID NO: 5) (Genbank D58422) , Erwinia herhicola EholO (SEQ ID NO.: 6) (GenBank M872280) , Erwinia uredovora (SEQ ID NO.: 7) (GenBank D90087) and Agrobacterium aurianticu (SEQ ID NO.: 8) (GenBank D58420) . A consensus sequence is also shown. Consensus is identical for all five genes where a capital letter appears. A lowercase letter indicates that three of five, including A. thaliana , have the identical' residue. TM; transmembrane Figure 7 is a DNA sequence of a cDNA encoding an IPP isomerase isolated from A . thaliana (SEQ ID NO: 9) . This cDNA is incorporated into the plasmid pATDP5. Figure 8 is a DNA sequence of a second cDNA encoding 'another IPP isomerase isolated from A. thaliana (SEQ ID NO: 10). This cDNA is incorporated into the plasmid pATDP7. Figure 9 is a DNA sequence of a cDNA encoding an IPP isomerase isolated from Haema tococcus pluviali ε (SEQ ID NO: 11) . This cDNA is incorporated into the plasmid pHP04. Figure 10 is a DNA sequence of a second cDNA encoding another IPP isomerase isolated from Haema tococcus pluvialis (SEQ ID NO: 12) . This cDNA is incorporated into the plasmid pHP05. Figure 11 is an alignment of the predicted ammo acid sequences of the IPP isomerase isolated from Λ . thaliana (SEQ ID NO . : 16 and 18 ) , H . pl uvial i s (SEQ ID NOS . . : 14 and 15 ) , Clarkia breweri (SEQ ID NO . : 11 ) (See, Blanc & Pichersky, Plant Physiol. (1995) 108:855; Genbank accession no. X82627) and Saccharomyces cerevisiae (SEQ ID NO.. 19) (Genbank accession no. J05090) . Figure 12 is a DNA sequence of the cDNA encoding an IPP isomerase isolated from marigold (SEQ ID NO: 13) . This cDNA is incorporated into the plasmid pPMDPl . xxx's denote a region not yet sequenced at the time when this applicaiton was prepared. -- Figure 13 is an alignment of the consensus sequence of 4 plant 3-cyclases (SEQ ID NO. : 20) with the A . thaliana c- cyclase (SEQ ID NO. : 21) A capital letter n the plant 3 consensus is used where all 4 B cyclase genes predict the same ' ammo acid residue in this position. A small letter indicates that an identical residue was found 3 or the . Dasnes inaicate that the am o acid residue was not conserved and dots in the sequence denote a gap. A consensus for the aligned sequences is given, in capital letters below the alignment, where the β and e cyclase have the same amino acid residue. Arrows indicate some of the conserved amino acids that will be used as junction sites for construction of chimeric cyclases with novel enzymatic activities. Several regions of interest including a sequence signature indicative of a dinucleotide-binding motif and 2 predicted transmembrane (TM) helical regions are indicated below the alignment and are underlined. DESCRIPTION OF THE PREFERRED EMBODIMENTS Isolated eukaryotic genes which encode enzymes involved in carotenoid biosynthesis The present inventors have now isolated eukaryotic genes encoding e cyclase and / S-carotene hydroxylase from A . thaliana and IPP isomerases from several sources. The present inventors have now isolated the eukaryotic gene encoding the enzyme IPP isomerase which catalyzes the conversion of isopentenyl pyrophosphate (IPP) to dimethylallyl pyrophosphate (DMAPP) . IPP isomerases were isolated from A. thaliana, H . pluvialis and marigold. Alignments of these are shown in Figure 12 (excluding the marigold sequence) . Plasmids containing these genes were ■deposited with the American Type Culture Collection, 12301 Parklawn Drive, Rockville MD 20852 on March 4, 1996 under ATCC accession numbers 98000 (pHP05 - H . pluvialis) ; 98001 (pMDPl - marigold) ; 98002 (pATDP7 - H. pluvialis ) and 98004 (pHP04 - H. pluvialis) . The present inventors have also isolated the gene encoding the enzyme, e cyclase, which is responsible for the formation of € endgroups in carotenoids. A gene encoding an e cyclase from any organism has not heretofore been described. The A. thaliane e cyclase adds an e-ring to only one end of the symmetrical lycopene while the related β-cyclase adds a ring at both ends . The DNA of the present invention is shown in Figure 4 and SEQ ID NO: 1. A plasmid containing this gene was deposited with the American Type Culture Collection, 12301 Parklawn Drive, Rockville MD 20852 on March 4, 1996 under ATCC accession number 98005 (pATeps - A. thaliana) . The present inventors have also isolated the gene encoding the enzyme, / 3-carotene hydroxylase, which is responsible for hydroxylating the β endgroup in carotenoids. The DNA of the present invention is shown in SEQ ID NO: 3 and Figure 5. The full length gene product hydroxylates both end groups of / 3-carotene as do products of genes which encode proteins truncated by up to 50 amino acids from the N- terminus. Products of genes which encode proteins truncated between about 60-110 amino acids from the N-terminus preferentially hydroxylates only one ring. A plasmid -containing this gene was deposited with the American Type Culture Collection, 12301 Parklawn Drive, Rockville MD 20852 on March 4, 1996 under ATCC accession number 98003 (pATOHB - A. thaliana ) . Eukaryotic genes which encode enzymes which produce novel or rare carotenoids The present invention also relates to novel enzymes which can transform known carotenoids into novel or rare products. That is, currently e-carotene (see figure 2) and γ-carotene can only be isolated in minor amounts. As described below, an enzyme can be produced which would transform lycopene to γ- carotene and lycopene to e-carotene. With these products in hand, bulk synthesis of other carotenoids derived from them are possible. For example, e-carotene can be hydroxylated to form an isomer of lutein (1 e- and 1 /S-ring) and zeaxanthin (2 0-rings) where both endgroups are, instead, e-rings. The eukaryotic genes in the carotenoid biosynthetic pathway differ from their prokaryotic counterparts in their 5' region. As used herein, the 5' region is the region of eukaryotic DNA which precedes the initiation codon of the counterpart gene in prokaryotic DNA. That is, when the consensus areas of eukaryotic and prokaryotic genes are aligned, the eukaryotic genes contain additional coding sequences upstream of the prokaryotic initiation codon. The present inventors have found that the amount of the 5' region present can alter the activity of the eukaryotic enzyme. Instead of diminishing activity, truncating the 5' region of the eukaryotic gene results in an enzyme with a different specificity. Thus, the present invention relates to enzymes which are truncated to within 0-50, preferably 0-25, codons of the 5' initiation codon of their prokaryotic counterparts as determined by alignment maps. For example, as discussed above, when the gene encoding A . thaliana / S-carotene hydroxylase was truncated, the resulting enzyme catalyzed the formation of /S-cryptoxanthin as major product and zeaxanthin as minor product; in contrast to its normal production of zeaxanthin. In addition to novel enzymes produced by truncating the 5' region of known enzymes, novel enzymes which can participate in the formation of novel carotenoids can be formed by replacing portions of one gene with an analogous sequence from a structurally related gene. For example, β- cyclase and e-cyclase are structurally related (see Figure 13) . By replacing a portion of 3-lycopene cyclase with the analogous portion of e-cyclase, an enzyme which produces γ- carotene will be produced (1 endgroup) . Further, by replacing a portion of the e-lycopene cyclase with the analogous portion of / 3-cyclase, an enzyme which produces e-carotene will be produced (e-cyclase normally produces a compound with 1 e- endgroup (δ-carotene) not 2) . Similarly, /3-hydroxylase could be modified to produce enzymes of novel function by creation of hybrids with e-hydroxylase. Vectors The genes encoding the carotenoid enzymes as described above, when cloned into a suitable expression vector, can be used to overexpress theεe enzymes in a plant expression system or to inhibit the expression of these enzymes. For example, "a ~ vector containing the gene encoding e-cyclase can be used to increase the amount of α-carotene in an organism and thereby alter the nutritional value, pharmacology and visual appearance value of the organism. In a preferred embodiment, the vectors of the present invention contain a DNA encoding an eukaryotic IPP isomerase upstream of a DNA encoding a second eukaryotic carotenoid enzyme. The inventors have discovered that inclusion of an IPP isomerase gene increases the supply of substrate for the carotenoid pathway; thereby enhancing the production of carotenoid endproducts. This is apparent from the much deeper pigmentation in carotenoid-accumulating colonies of E. coli which also contain one of the aforementioned IPP isomerase genes when compared to colonies that lack this additional IPP isomerase gene. Similarly, a vector comprising an IPP isomerase gene can be used to enhance production of any secondary metabolite of dimethylallyl pyrophosphate (such as isoprenoids, steroids, carotenoids, etc.). Alternatively, an anti-sense strand of one of the above genes can be inserted into a vector. For example, the e- cyclase gene can be inserted into a vector and incorporated into the genomic DNA of a host, thereby inhibiting the synthesis of e, β carotenoids (lutein and α-carotene) and enhancing the synthesis of β , β carotenoids (zeaxanthin and β- carotene) . Suitable vectors according to the present invention comprise a eukaryotic gene encoding an enzyme involved in carotenoid biosynthesis or metabolism and a suitable promoter for the host can be constructed using techniques well known in the art (for example Sambrook et al., Molecular Cloning A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989). Suitable vectors for eukaryotic expression in plants are described in Frey et al., Plant J. (1995) 8(5):693 and Misawa et al, 1994a; incorporated herein by reference. Suitable vectors for prokaryotic expression include PACYC184, pUC119, and pBR322 (available from New England BioLabs, Bevery, MA) and pTreHis (Invitrogen) and pET28 (Novagene) and derivatives thereof. The vectors of the present invention can additionally contain regulatory elements such as promoters, repressors selectable markers such as antibiotic resistance genes, etc. Hosts Host systems according to the present invention can comprise any organism that already produces carotenoids or which has been genetically modified to produce carotenoids. The IPP isomerase genes are more broadly applicable for enhancing production of any product dependent on DMAPP as a precursor. Organisms which already produce carotenoids include plants, algae, some yeasts, fungi and cyanobacteria and other photosynthetic bacteria. Transformation of these hosts with vectors according to the present invention can be done using standard techniques such as those described in Misawa et al., (1990) supra; Hundle et al., (1993) supra; Hundle et al., (1991) supra; Misawa et al., (1991) supra; Sandmann et al., supra; and Scnurr et al., supra; all incorporated herein by reference. Alternatively, transgenic organisms can be constructed which include the DNA sequences of the present invention (Bird et al, 1991; Bramley et al, 1992; Misawa et al, 1994a; Misawa et al, 1994b; Cunningham et al, 1993). The incorporation of these sequences can allow the controlling of carotenoid biosynthesis, content, or composition in the host cell. These transgenic systems can be constructed to incorporate sequences which allow over-expression of the carotenoid genes of the present invention. Transgenic systems can also be constructed containing antisense expression of the DNA sequences of the present invention. Such antisense expression would result in the accumulation of the substrates of the substrates of the enzyme encoded by the sense strand. A method for screening for eukarvotic genes which encode enzymes involved in carotenoid biosynthesis The method of the present invention comprises transforming a prokaryotic host with a DNA which may contain a eukaryotic or prokaryotic carotenoid biosynthetic gene; culturing said transformed host to obtain colonies; and screening for colonies exhibiting a different color than colonies of the untransformed host. Suitable hosts include E. coli, cyanobacteria such as Synechococcus and Synechocystis, alga and plant cells. E. coli are preferred. In a preferred embodiment, the above "color complementation test" can be enhanced by using mutants which are either (1) deficient in at least one carotenoid biosynthetic gene or (2) overexpress at least one carotenoid biosynthetic gene. In either case, such mutants will accumulate carotenoid precursors. Prokaryotic and eukaryotic DNA libraries can be screened in total for the presence of genes of carotenoid biosynthesis, metabolism and degradation. Preferred organisms to be screened include photosynthetic organisms. E. coli can be transformed with these eukaryotic cDNA libraries using conventional methods such as those described in Sambrook et al, 1989 and according to protocols described by the venders of the cloning vectors. For example, the cDNA libraries in bacteriophage vectors such as lambdaZAP (Stratagene) or lambdaZIPOLOX (Gibco BRL) can be excised en masse and used to transform E. coli can be inserted into suitable vectors and these vectors can the be used to transform E. coli . Suitable vectors include pACYC184, pUC119, pBR322 (available from New England BioLabs, Bevery, MA) . pACYC is preferred. Transformed E . coli can be cultured using conventional techniques. The culture broth preferably contains antibiotics to select and maintain plasmids. Suitable antibiotics include penicillin, ampicillin, chloramphenicol, etc. Culturing is typically conducted at 20-40°C, preferably at room temperature (20-25°C) , for 12 hours to 7 days. Cultures are plated and the plates are screened visually for colonies with a different color than the colonies of the untransfoπned host E. coli . For example, E. coli transformed with the plasmid, pAC-BETA (described below) , produce yellow colonies that accumulate /S-carotene. After transformation with a cDNA library, colonies which contain a different hue than those formed by E. coli/pAC-BETA would be expected to contain enzymes which modify the structure or degree of expression of /3-carotene. Similar standards can be engineered which overexpress earlier products in carotenoid biosynthesis, such as lycopene, γ-carotene, etc. Having generally described this invention, a further understanding can be obtained by reference to certain specific examples which are provided herein for purposes of illustration only and are not intended to be limiting unless otherwise specified. EXAMPLE I. Isolation of 0-carotene hydroxylase Plasmid Construction An 8.6kb Bglll fragment containing the carotenoid biosynthetic genes of Erwinia herbicola was first cloned in the BamHI site of plasmid vector pACYC184 (chloramphenicol resistant), and then a l.lkb BamHI fragment containing the β- carotene hydroxylase (CrtZ) was deleted. The resulting plasmid, pAC-BETA, contains all the genes for the formation of β-carotene. .E.coli strains containing this plasmid accumulate β-carotene and form yellow colonies (Cunningham et al., 1994). A full length gene encoding IPP isomerase of Haematococcus pluvialis (HP04) was first cut out with BamHI- Kpnl from pBluescript SK+, and then cloned into a pTrcHisA vector with high-level expression from the trc promoter (Invitrogen Inc.).— A fragment containing the IPP isomerase and trc promoter was excised with EcoRV-Kpnl and cloned in Hindlll site of pAC-BETA. E. coli cells transformed with this new plasmid pAC-BETA-04 form orange (deep yellow) colonies on LB plates and accumulate more / S-carotene than cells that contain pAC-BETA. Screening of the Arabidopsis cDNA Library Several λ cDNA expression libraries of Arabidopsis were obtained from the Arabidopsis Biological Resource Center (Ohio State University, Columbus, OH) (Kieber et al. , 1993). The λ cDNA libraries were excised in vivo using Stratagene's ExAssist SOLR system to produce a phagemid cDNA library wherein each clone also contained an amphicillin. E. coli strain DH10BZIP was chosen as the host cells for the screening and pigment production. DH10B cells were transformed with plasmid pAC-BETA-04 and were plated on LB agar plates containing chloramphenicol at 50 μg/ml (from United States Biochemical Corporation) . The phagemid AraJidopsis cDNA library was then introduced into DH10B cells already containing pAC-BETA-04. Transformed cells containing both pAC-BETA-04 and Arabidopsis cDNA were selected on chloramphenicol plus ampicillin (150 μg/ml) agar plates. Maximum color development occurred after 5 days incubation at room temperature, and lighter yellow colonies were selected. Selected colonies were inoculated into 3 ml liquid LB medium containing ampicillin and chloramphenicol, and cultures were incubated. Cells were then pelleted and extracted in 80 μl 100% acetone in microfuge tubes. After centrifugation, pigmented supernatant was spotted on silica gel thin-layer chromatography (TLC) plates, and developed with a hexane; ether (1:1) solvent system, β-carotene hydroxylase clones were identified based on the appearance of zeaxanthin on TLC plate. Subcloning and Sequencing The β-carotene hydroxylase cDNA was isolated by standard procedures (Sambrook et al., 1989). Restriction maps showed that three independent inserts (1.9kb, 0.9kb and 0.8kb) existed in the cDNA. To determine which cDNA insert confers the β-carotene hydroxylase activity, plasmid DNA was digested with NotI (a site in the adaptor of the cDNA library) and three inserts were subcloned into NotI site of SK vectors. These subclones were used to transform E. coli cells containing pAC-BETA-04 again to test the hydroxylase activity. A fragment of 0.95kb, later shown to contain the hydroxylase gene, was also blunt-ended and cloned into pTrcHis A,B,C vectors. To remove the N terminal sequence, a restriction site (Bglll) was used that lies just before the conserved sequence with bacterial genes. A Bglll-Xhol fragment was directionally cloned in BamHI-XhoI digested trc vectors. Functional clones were identified by the color complementation test. A 3-carotene hydroxylase enzyme produces a colony with a lighter yellow color than is found in cells containing pAC- BETA-04 alone. Arabidopsis β-carotene hydroxylase was sequenced completely on both strands on an automatic sequencer (Applied Biosystems, Model 373A, Version 2.0.IS). Pigment Analysis A single colony was used to inoculate 50 ml of LB containing ampicillin and chloramphenicol in a 250-ml flask. Cultures were incubated at 28°C for 36 hours with gentle shaking, and then harvested at 5000 rpm in an SS-34 rotor. The cells were washed once with distilled H 2 0 and resuspended with 0.5 ml of water. The extraction procedures and HPLC were essentially as described previously (Cunningham et al, 1994) . II. Isolation of e cyclase Plasmid Construction Construction of plasmids pAC-LYC, pAC-NEUR, and pAC-ZETA is described in Cunningham et al., (1994). In brief, the appropriate carotenoid biosynthetic genes from Erwinia herbicola , Rhodobacter capsulatus , and Synechococcus sp. strain PCC7942 were cloned in the plasmid vector pACYC184 (New England BioLabs, Beverly, MA) . Cultures of E. coli containing the plasmids pAC-ZETA, pAC-NEUR, and pAC-LYC, accumulate ζ- 'carotene, neurosporene, and lycopene, respectively. The plasmid pAC-ZETA was constructed as follows: an 8.6-kb Bglll fragment containing the carotenoid biosynthetic genes of E . herbicola (GenBank M87280; Hundle et al., 1991) was obtained after partial digestion of plasmid pPL376 (Perry et al., 1986; Tuveson et al., 1986) and cloned in the BamHI site of pACYC184 to give the plasmid pAC-EHER. Deletion of adjacent 0.8- and 1.1-kb BamHI-BamHI fragments (deletion Z in Cunningham et al., 1994), and of a 1.1 kB Sall-Sall fragment (deletion X) served to remove most of the coding regions for the E . herbicola β- carotene hydroxylase (crt gene) and zeaxanthin glucosyltransferase (crtx gene) , respectively. The resulting plasmid, pAC-BETA, retains functional genes for geranylgeranyl pyrophosphate synthase (crtE) , phytoene synthase (crtB) , phytoene desaturase (crtl) , and lycopene cyclase (crtY) . Cells of E. coli containing this plasmid form yellow colonies and accumulate (β-carotene. A plasmid containing both the e- and β-cyclase cDNAs of A . thaliana was constructed by excising the e cyclase in clone y2 as a PvuI-PvuII fragment and ligating this piece in the SnaBI site of a plasmid (pSPORT 1 from GIBCO-BRL) that already contained the β cyclase. Organisms and Growth conditions E . coli strains TOP10 and TOP10 F' (obtained from Invitrogen Corporation, San Diego, CA) and XLl-Blue iStratagene) were grown in Luria-Bertani (LB) medium (Sambrook et al., 1989) at 37°C in darkness on a platform shaker at 225 cycles per min. Media components were from Difco (yeast extract and tryptone) or Sigma (NaCl) . Ampicillin at 150 μg/mL and/or chloramphenicol at 50 μg/mL (both from United States Biochemical Corporation) were used, as appropriate, for selection and maintenance of plasmids. Mass Excision and Color Complementation Screening of an A. thaliana cDNA Library A size-fractionated 1-2 kB cDNA library of A . thaliana in lambda ZAPII (Kieber et al. , 1993) was obtained from the Arabidopsis Biological Resource Center at The Ohio State University (stock number CD4-14) . Other size fractionated libraries were also obtained (stock numbers CD4-13, CD4-15, and CD4-16) . An aliquot of each library was treated to cause a mass excision of the cDNAs and thereby produce a phagemid library according to the instructions provided by the supplier of the cloning vector (Stratagene; E . coli strain XLl-Blue and the helper phage R408 were used) . The titre of the excised phagemid was determined and the library was introduced into a lycopene-accumulating strain of E. coli TOP10 F' (this strain contained the plasmid pAC-LYC) by incubation of the phagemid with the E. coli cells for 15 min at 37°C. Cells had been grown overnight at 30°C in LB medium supplemented with 2% (w/v) maltose and 10 mM MgS0 < (final concentration) , and harvested in 1.5 ml ^ _microfuge tubes at a setting of 3 on an Eppendorf microfuge (5415C) for 10 min. The pellets were resuspended in 10 mM MgS0 4 to a volume equal to one-half that of the initial culture volume. Transformants were spread on large (150 mm diameter) LB agar petri plates containing antibiotics to provide for selection of cDNA clones (ampicillin) and maintenance of pAC-LYC (chloramphenicol) . Approximately 10,000 colony forming units were spread on each plate. Petri plates were incubated at 37-C for 16 hr and then at room temperature for 2 to 7 days to allow maximum color development. Plates were screened visually with the aid of an illuminated 3x magnifier and a low power stage-dissecting microscope for the rare, pale pinkish-yellow to deep-yellow colonies that could be observed in the background of pink colonies. A colony color of yellow or pinkish-yellow was taken as presumptive evidence of a cyclization activity. These yellow colonies were collected with sterile toothpicks and used to inoculate 3ml of LB medium in culture tubes with overnight growth at 37°C and shaking at 225 cycles/min. Cultures were split into two aliquots in microfuge tubes and harvested by centrifugation at a setting of 5 in an Eppendorf 5415C microfuge. After discarding the liquid, one pellet was frozen for later purification of plasmid DNA. To the second pellet was added 1.5 ml EtOH, and the pellet was resuspended by vortex mixing, and extraction was allowed to proceed in the dark for 15-30 min with occasional remixing. Insoluble materials were pelleted by centrifugation at maximum speed for 10 min in a microfuge. Absorption spectra of the supernatant fluids were recorded from 350-550 nm with a Perkin Elmer lambda six spectrophotometer. Analysis of isolated clones Eight of the yellow colonies contained S-carotene indicating that a single gene product catalyzes both cyclizations required to form the two β endgroups of the symmetrical / 3-carotene from the symmetrical precursor lycopene. One of the yellow colonies contained a pigment with the spectrum characteristic of δ-carotene, a monocyclic carotenoid with a single e endgroup. Unlike the β cyclase, this e cyclase appears unable to carry out a second cyclization at the other end of the molecule. The observation that e cyclase is unable to form two cyclic e endgroups (e.g. the bicyclic e-carotene) illuminates the mechanism by which plants can coordinate and control the flow of substrate into carotenoids derived from β-carotene versus those derived from α-carotene and also can prevent the formation of carotenoids with two e endgroups. The availability of the A . thaliana gene encoding the e cyclase enables the directed manipulation of plant and algal species for modification of carotenoid content and composition. Through inactivation of the e cyclase, whether at the gene level by deletion of the gene or by insertional inactivation or by reduction of the amount of enzyme formed (by such as antisense technology) , one may increase the formation of / 3-carotene and other pigments derived from it. Since vitamin A is derived only from carotenoids with β endgroups, an enhancement of the production of (β-carotene versus α-carotene may enhance nutritional value of crop plants. Reduction of carotenoids with e endgroups may also be of value in modifying the color properties of crop plants and specific tissues of these plants. Alternatively, where production of α-carotene, or pigments such as lutein that are derived from α-carotene, is desirable, whether for the color properties, nutritional value or other reason, one may overexpress the e cyclase or express it in specific tissues. Wherever agronomic value of a crop is related to pigmentation provided by carotenoid pigments the directed manipulation of expression of the e cyclase gene and/or production of the enzyme may be of commercial value. The predicted amino acid sequence of the A. thaliana e cyclase enzyme was determined. A comparison of the amino acid sequences of the β and e cyclase enzymes of Arabidopsis thaliana (Fig. 13) as predicted by the DNA sequence of the respective genes (Fig. 4 for the e cyclase cDNA sequence) , indicates that these two enzymes have many regions of sequence similarity, but they are only about 37% identical overall at the amino acid level. The degree of sequence identity at the DNA base level, only about 50%, is sufficiently low such that we and others have been unable to detect this gene by hybridization using the β cyclase as a probe in DNA gel blot experiments. REFERENCES Bird et al, 1991 Biotechnology 9, 635-639. Bishop et al., (1995) FEBS Lett. 367, 158-162. Bramley, P.M. (1985) Adv. Lipid Res. 21, 243-279. Bramley, P.M. (1992) Plant J. 2, 343-349. Britton, G. (1988) . Biosynthesis of carotenoids. In Plant Pigments, T.W. Goodwin, ed. (London: Academic Press), pp. 133- 182. Britton, G. (1979) Z. Naturforsch. Section C Biosci. 34, 979-985. Britton, G. (1995) UV/Visible spectroscopy. In Carotenoids, Vol. IB: Spectroscopy, G. Britton, S. Liaaen- Jensen, H.P. Pfander, eds. (Basel: Birkhauser Verlag) , pp. 13- 62. Bouvier et al., (1994) Plant J. 6, 45-54. Cunningham et al., (1985) Photochem. Photobiol. 42: 295- 307 Cunningham et al., (1993) FEBS Lett. 328, 130-138. Cunningham et al., (1994) Plant Cell 6, 1107-1121. Davies, B.H. (1976). Carotenoids. In Chemistry and Biochemistry of Plant Pigments, Vol. 2, T.W. Goodwin, ed (New York: Academic Press), pp. 38-165. Del Sal et al., (1988). Nucl. Acids Res. 16, 9878. Demmig-Adams & Adams, (1992) Ann. Rev. Plant Physiol. Mol. Biol. 43, 599-526. Enzell & Back, (1995) Mass spectrometry. In Carotenoids, Vol. IB: Spectroscopy, G. Britton, S. Liaaen-Jensen, H.P. Pfander, eds. (Basel: Birkhauser Verlag) , pp. 261-320. Frank & Cogdell (1993) Photochemistry and function of carotenoids in photosynthesis. In Carotenoids in Photosynthesis. A. Young and G. Britton, eds. (London: Chapman and Hall) , pp. 253-326. Goodwin, T.W. (1980) . The Biochemistry of the Carotenoids. 2nd ed, Vol. 1 (London: Chapman and Hall. Horvath et al., (1972) Phytochem. 11, 183-187. Hugueney et al., (1995) Plant J. 8, 417-424. Hundle et al., (1991) Photoche . Photobiol. 54, 89-93. Jensen & Jensen, (1971) Methods Enzymol. 23, 586-602. Kargl & Quackenbush, (1960) Archives Biochem. Biophys. 88, 59-63. Kargl et al., (1960) Proc. Am. Hort. Soc. 75, 574-578. Kieber et al. , (1993) Cell 72, 427-441. Koyama, Y. (1991) J. Photochem. Photobiol., B, 9, 265-80. Krinsky, N.I. (1987) Medical uses of carotenoids. In Carotenoids, N.I. Krinsky, M.M. Mathews-Roth, and R.F. Taylor, eds. (New York: Plenum) , pp. 195-206. Kyte & Doolittle, (1982) J. Mol. Biol. 157, 105-132. LaRossa & Schloss, (1984) J. Biol. Chem. 259, 8753-8757. Misawa et al., (1994a) Plant J. 6, 481-489. Misawa et al., (1994b) J. Biochem, Tokyo, 116, 980-985. Norris et al., (1995) Plant Cell 7, 2139-2149. Pecker et al., (1996) Submitted to Plant Mni. Biol. Perry et al., (1986) J. Bacteriol. 168, 607-612. Persson & Argos, (1994) J. Mol. Biol. 237, 182-192. Plumley & Schmidt, (1987) Proc. Nat. Acad. Sci. USA 83, 146-150. Plumley & Schmidt, (1995) Plant Cell 7, 689-704. Ross ann et al., (1974) Nature 250, 194-199. Rock & Zeevaart (1991) Proc. Nat. Acad. Sci. USA 88, 7496-7499. Rost et al., (1995) Protein Science 4, 521-533. Sambrook et al., (1989) Molecular Cloning: A Laboratory Manual, 2nd edition (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press) . Sancar, A. (1994) Biochemistry 33, 2-9. Sander & Schneider, (1991) Proteins 9, 56-68. Sandmann, G. (1994) Eur. J. Biochem. 223, 7-24. Scolnik & Bartley, (1995) Plant Physiol. 108, 1342. Siefermann-Harms, D. (1987) Physiol. Plant. 69, 561-568. Spurgeon & Porter, (1980). Biosynthesis of carotenoids. In Biochemistry of Isoprenoid Compounds, J.W. Porter, and S.L. Spurgeon, eds. (New York: Wiley), pp. 1-122. Tomes, M.L. (1963) Bot. Gaz. 124, 180-185. Tomes, M.L. (1967) Genetics 56, 227-232. Tuveson et al. , (1986) J. Bacteriol. 170, 4675-4680. Van Beeumen et al., (1991) J. Biol. Chem. 266, 12921- 12931. Weedon & Moss, (1995) Structure and Nomenclature. In Carotenoids, Vol. IB: Spectroscopy, G. Britton, S. Liaaen- Jensen, H.P. Pfander, eds. (Basel: Birkhauser Verlag) , pp. 27- 70. Wierenga et al., (1986) J. Mol. Biol. 187, 101-107. Zechmeister, L. (1962) Cis-Trans Isomeric Carotenoids, Vitamins A and Arylpolyenes. Springer-Verlag, Vienna. Having now fully described the invention, it will be apparent to one of ordinary skill in the art that many changes and modifications can be made thereto without departing from the spirit or scope of the invention as set forth herein. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: CUNNINGHAM JR., FRANCIS X. SUN, ZAIREN (ii) TITLE OF INVENTION: GENES OF CAROTENOID BIOSYNTHESIS AND METABOLISM AND A SYSTEM FOR SCREENING SUCH GENES (iii) NUMBER OF SEQUENCES: 21 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: OBLON, SPIVAK, MCCLELLAND, MAIER & NEUSTADT, P.C. (B) STREET: 1755 S. JEFFERSON DAVIS HIGHWAY, SUITE 400 (C) CITY: ARLINGTON (D) STATE: VA (E) COUNTRY: USA (F) ZIP: 22202 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: US 08/624,125 (B) FILING DATE: 29-MAR-1996 (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: KELBER, STEVEN B. (B) REGISTRATION NUMBER: 30,073 (C) REFERENCE/DOCKET NUMBER: 2747-063-27 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 703-413-3000 (B) TELEFAX: 703-413-2220 (2) INFORMATION FOR SEQ ID NO: 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1860 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 109..1680 (D) OTHER INFORMATION: /product= "E-CYCLASE FROM A. THALIANA" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1 : ACAAAAGGAA ATAATTAGAT TCCTCTTTCT GCTTGCTATA CCTTGATAGA ACAATATAAC 60 AATGGTGTAA GTCTTCTCGC TGTATTCGAA ATTATTTGGA GGAGGAAA ATG GAG TGT 117 Met Glu Cys 1 GTT GGG GCT AGG AAT TTC GCA GCA ATG GCG GTT TCA ACA TTT CCG TCA 165 Val Gly Ala Arg Asn Phe Ala Ala Met Ala Val Ser Thr Phe Pro Ser 5 10 15 TGG AGT TGT CGA AGG AAA TTT CCA GTG GTT AAG AGA TAC AGC TAT AGG 213 Trp Ser Cys Arg Arg Lys Phe Pro Val Val Lys Arg Tyr Ser Tyr Arg 20 25 30 35 AAT ATT CGT TTC GGT TTG TGT AGT GTC AGA GCT AGC GGC GGC GGA AGT 261 Asn lie Arg Phe Gly Leu Cys Ser Val Arg Ala Ser Gly Gly Gly Ser 40 45 50 TCC GGT AGT GAG AGT TGT GTA GCG GTG AGA GAA GAT TTC GCT GAC GAA 309 Ser Gly Ser Glu Ser Cys Val Ala Val Arg Glu Asp Phe Ala Asp Glu 55 60 65 GAA GAT TTT GTG AAA GCT GGT GGT TCT GAG ATT CTA TTT GTT CAA ATG 357 Glu Asp Phe Val Lys Ala Gly Gly Ser Glu lie Leu Phe Val Gin Met 70 75 80 CAG CAG AAC AAA GAT ATG GAT GAA CAG TCT AAG CTT GTT GAT AAG TTG 405 Gin Gin Asn Lys Asp Met Asp Glu Gin Ser Lys Leu Val Asp Lys Leu 85 90 95 CCT CCT ATA TCA ATT GGT GAT GGT GCT TTG GAT CAT GTG GTT ATT GGT 453 Pro Pro lie Ser lie Gly Asp Gly Ala Leu Asp His Val Val lie Gly 100 105 110 115 TGT GGT CCT GCT GGT TTA GCC TTG GCT GCA GAA TCA GCT AAG CTT GGA 501 Cys Gly Pro Ala Gly Leu Ala Leu Ala Ala Glu Ser Ala Lys Leu Gly 120 125 130 TTA AAA GTT GGA CTC ATT GGT CCA GAT CTT CCT TTT ACT AAC AAT TAC 549 Leu Lys Val Gly Leu lie Gly Pro Asp Leu Pro Phe Thr Asn Asn Tyr 135 140 145 GGT GTT TGG GAA GAT GAA TTC AAT GAT CTT GGG CTG CAA AAA TGT ATT 597 Gly Val Trp Glu Asp Glu Phe Asn Asp Leu Gly Leu Gin Lys Cys He 150 155 160 GAG CAT GTT TGG AGA GAG ACT ATT GTG TAT CTG GAT GAT GAC AAG CCT 645 Glu His Val Trp Arg Glu Thr He Val Tyr Leu Asp Asp Asp Lys Pro 165 170 175 ATT ACC ATT GGC CGT GCT TAT GGA AGA GTT AGT CGA CGT TTG CTC CAT 693 He Thr He Gly Arg Ala Tyr Gly Arg Val Ser Arg Arg Leu Leu His 180 185 190 195 GAG GAG CTT TTG AGG AGG TGT GTC GAG TCA GGT GTC TCG TAC CTT AGC 741 Glu Glu Leu Leu Arg Arg Cys Val Glu Ser Gly Val Ser Tyr Leu Ser 200 205 210 TCG AAA GTT GAC AGC ATA ACA GAA GCT TCT GAT GGC CTT AGA CTT GTT 789 Ser Lys Val Asp Ser He Thr Glu Ala Ser Asp Gly Leu Arg Leu Val 215 220 225 GCT TGT GAC GAC AAT AAC GTC ATT CCC TGC AGG CTT GCC ACT GTT GCT 837 Ala Cys Asp Asp Asn Asn Val He Pro Cys Arg Leu Ala Thr Val Ala 230 235 240 TCT GGA GCA GCT TCG GGA AAG CTC TTG CAA TAC GAA GTT GGT GGA CCT 885 Ser Gly Ala Ala Ser Gly Lys Leu Leu Gin Tyr Glu Val Gly Gly Pro 245 250 255 AGA GTC TGT GTG CAA ACT GCA TAC GGC GTG GAG GTT GAG GTG GAA AAT 933 Arg Val Cys Val Gin Thr Ala Tyr Gly Val Glu Val Glu Val Glu Asn 260 265 270 275 AGT CCA TAT GAT CCA GAT CAA ATG GTT TTC ATG GAT TAC AGA GAT TAT 981 Ser Pro Tyr Asp Pro Asp Gin Met Val Phe Met Asp Tyr Arg Asp Tyr 280 285 290 ACT AAC GAG AAA GTT CGG AGC TTA GAA GCT GAG TAT CCA ACG TTT CTG 1029 Thr Asn Glu Lys Val Arg Ser Leu Glu Ala Glu Tyr Pro Thr Phe Leu 295 300 305 TAC GCC ATG CCT ATG ACA AAG TCA AGA CTC TTC TTC GAG GAG ACA TGT 1077 Tyr Ala Met Pro Met Thr Lys Ser Arg Leu Phe Phe Glu Glu Thr Cys 310 315 320 TTG GCC TCA AAA GAT GTC ATG CCC TTT GAT TTG CTA AAA ACG AAG CTC 1125 Leu Ala Ser Lys Asp Val Met Pro Phe Asp Leu Leu Lys Thr Lys Leu 325 330 335 ATG TTA AGA TTA GAT ACA CTC GGA ATT CGA ATT CTA AAG ACT TAC GAA 1173 Met Leu Arg Leu Asp Thr Leu Gly He Arg He Leu Lys Thr Tyr Glu 340 345 350 355 GAG GAG TGG TCC TAT ATC CCA GTT GGT GGT TCC TTG CCA AAC ACC GAA 1221 Glu Glu Trp Ser Tyr He Pro Val Gly Gly Ser Leu Pro Asn Thr Glu 360 365 370 CAA AAG AAT CTC GCC TTT GGT GCT GCC GCT AGC ATG GTA CAT CCC GCA 1269 Gin Lys Asn Leu Ala Phe Gly Ala Ala Ala Ser Met Val His Pro Ala 375 380 385 ACA GGC TAT TCA GTT GTG AGA TCT TTG TCT GAA GCT CCA AAA TAT GCA 1317 Thr Gly Tyr Ser Val Val Arg Ser Leu Ser Glu Ala Pro Lys Tyr Ala 390 395 400 TCA GTC ATC GCA GAG ATA CTA AGA GAA GAG ACT ACC AAA CAG ATC AAC 1365 Ser Val He Ala Glu He Leu Arg Glu Glu Thr Thr Lys Gin He Asn 405 410 415 AGT AAT ATT TCA AGA CAA GCT TGG GAT ACT TTA TGG CCA CCA GAA AGG 1413 SUBSTTTUTE SHEET (RULE 26) Ser Asn He Ser Arg Gin Ala Trp Asp Thr Leu Trp Pro Pro Glu Arg 420 425 430 435 AAA AGA CAG AGA GCA TTC TTT CTC TTT GGT CTT GCA CTC ATA GTT CAA 1461 Lys Arg Gin Arg Ala Phe Phe Leu Phe Gly Leu Ala Leu He Val Gin 440 445 450 TTC GAT ACC GAA GGC ATT AGA AGC TTC TTC CGT ACT TTC TTC CGC CTT 1509 Phe Asp Thr Glu Gly He Arg Ser Phe Phe Arg Thr Phe Phe Arg Leu 455 460 465 CCA AAA TGG ATG TGG CAA GGG TTT CTA GGA TCA ACA TTA ACA TCA GGA 1557 Pro Lys Trp Met Trp Gin Gly Phe Leu Gly Ser Thr Leu Thr Ser Gly 470 475 480 GAT CTC GTT CTC TTT GCT TTA TAC ATG TTC GTC ATT TCA CCA AAC AAT 1605 Asp Leu Val Leu Phe Ala Leu Tyr Met Phe Val He Ser Pro Asn Asn 485 490 495 TTG AGA AAA GGT CTC ATC AAT CAT CTC ATC TCT GAT CCA ACC GGA GCA 1653 Leu Arg Lys Gly Leu He Asn His Leu He Ser Asp Pro Thr Gly Ala 500 505 510 515 ACC ATG ATA AAA ACC TAT CTC AAA GTA TGATTTACTT ATCAACTCTT 1700 Thr Met He Lys Thr Tyr Leu Lys Val 520 AGGTTTGTGT ATATATATGT TGATTTATCT GAATAATCGA TCAAAGAATG GTATGTGGGT 1760 TACTAGGAAG TTGGAAACAA ACATGTATAG AATCTAAGGA GTGATCGAAA TGGAGATGGA 1820 AACGAAAAGA AAAAAATCAG TCTTTGTTTT GTGGTTAGTG 1860 (2) INFORMATION FOR SEQ ID NO:2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 524 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Glu Cys Val Gly Ala Arg Asn Phe Ala Ala Met Ala Val Ser Thr 1 5 10 15 Phe Pro Ser Trp Ser Cys Arg Arg Lys Phe Pro Val Val Lys Arg Tyr 20 25 30 Ser Tyr Arg Asn He Arg Phe Gly Leu Cys Ser Val Arg Ala Ser Gly 35 40 45 Gly Gly Ser Ser Gly Ser Glu Ser Cys Val Ala Val Arg Glu Asp Phe 50 55 60 Ala Asp Glu Glu Asp Phe Val Lys Ala Gly Gly Ser Glu He Leu Phe 65 70 75 80 Val Gin Met Gin Gin Asn Lys Asp Met Asp Glu Gin Ser Lys Leu Val 85 90 95 Asp Lys Leu Pro Pro He Ser He Gly Asp Gly Ala Leu Asp His Val 100 105 110 Val He Gly Cys Gly Pro Ala Gly Leu Ala Leu Ala Ala Glu Ser Ala 115 120 125 Lys Leu Gly Leu Lys Val Gly Leu He Gly Pro Asp Leu Pro Phe Thr 130 135 140 Asn Asn Tyr Gly Val Trp Glu Asp Glu Phe Asn Asp Leu Gly Leu Gin 145 150 155 160 Lys Cys He Glu His Val Trp Arg Glu Thr He Val Tyr Leu Asp Asp 165 170 175 Asp Lys Pro He Thr He Gly Arg Ala Tyr Gly Arg Val Ser Arg Arg 180 185 190 Leu Leu His Glu Glu Leu Leu Arg Arg Cys Val Glu Ser Gly Val Ser 195 200 205 Tyr Leu Ser Ser Lys Val Asp Ser He Thr Glu Ala Ser Asp Gly Leu 210 215 220 Arg Leu Val Ala Cys Asp Asp Asn Asn Val He Pro Cys Arg Leu Ala 225 230 235 240 Thr Val Ala Ser Gly Ala Ala Ser Gly Lys Leu Leu Gin Tyr Glu Val 245 250 255 Gly Gly Pro Arg Val Cys Val Gin Thr Ala Tyr Gly Val Glu Val Glu 260 265 270 Val Glu Asn Ser Pro Tyr Asp Pro Asp Gin Met Val Phe Met Asp Tyr 275 280 285 Arg Asp Tyr Thr Asn Glu Lys Val Arg Ser Leu Glu Ala Glu Tyr Pro 290 295 300 Thr Phe Leu Tyr Ala Met Pro Met Thr Lys Ser Arg Leu Phe Phe Glu 305 310 315 320 Glu Thr Cys Leu Ala Ser Lys Asp Val Met Pro Phe Asp Leu Leu Lys 325 330 335 Thr Lys Leu Met Leu Arg Leu Asp Thr Leu Gly He Arg He Leu Lys 340 345 350 Thr Tyr Glu Glu Glu Trp Ser Tyr He Pro Val Gly Gly Ser Leu Pro 355 360 365 SUBSTTTUTESHEET(RULE26) Asn Thr Glu Gin Lys Asn Leu Ala Phe Gly Ala Ala Ala Ser Met Val 370 375 380 His Pro Ala Thr Gly Tyr Ser Val Val Arg Ser Leu Ser Glu Ala Pro 385 390 395 400 Lys Tyr Ala Ser Val He Ala Glu He Leu Arg Glu Glu Thr Thr Lys 405 410 415 Gin He Asn Ser Asn He Ser Arg Gin Ala Trp Asp Thr Leu Trp Pro 420 425 430 Pro Glu Arg Lys Arg Gin Arg Ala Phe Phe Leu Phe Gly Leu Ala Leu 435 440 445 He Val Gin Phe Asp Thr Glu Gly He Arg Ser Phe Phe Arg Thr Phe 450 455 460 Phe Arg Leu Pro Lys Trp Met Trp Gin Gly Phe Leu Gly Ser Thr Leu 465 470 475 480 Thr Ser Gly Asp Leu Val Leu Phe Ala Leu Tyr Met Phe Val He Ser 485 490 495 Pro Asn Asn Leu Arg Lys Gly Leu He Asn His Leu He Ser Asp Pro 500 505 510 Thr Gly Ala Thr Met He Lys Thr Tyr Leu Lys Val 515 520 (2) INFORMATION FOR SEQ ID NO:3 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 956 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3 : GCTCTTTCTC CTCCTCCTCT ACCGATTTCC GACTCCGCCT CCCGAAATCC TTATCCGGAT 60 TCTCTCCGTC TCTTCGATTT AAACGCTTTT CTGTCTGTTA CGTCGTCGAA GAACGGAGAC 120 AGAATTCTCC GATTGAGAAC GATGAGAGAC CGGAGAGCAC GAGCTCCACA AACGCTATAG 180 ACGCTGAGTA TCTGGCGTTG CGTTTGGCGG AGAAATTGGA GAGGAAGAAA TCGGAGAGGT 240 CCACTTATCT AATCGCTGCT ATGTTGTCGA GCTTTGGTAT CACTTCTATG GCTGTTATGG 300 CTGTTTACTA CAGATTCTCT TGGCAAATGG AGGGAGGTGA GATCTCAATG TTGGAAATGT 360 TTGGTACATT TGCTCTCTCT GTTGGTGCTG CTGTTGGTAT GGAATTCTGG GCAAGATGGG 420 CTCATAGAGC TCTGTGGCAC GCTTCTCTAT GGAATATGCA TGAGTCACAT CACAAACCAA 480 GAGAAGGACC GTTTGAGCTA AACGATGTTT TTGCTATAGT GAACGCTGGT CCAGCGATTG 540 GTCTCCTCTC TTATGGATTC TTCAATAAAG GACTCGTTCC TGGTCTCTGC TTTGGCGCCG 600 GGTTAGGCAT AACGGTGTTT GGAATCGCCT ACATGTTTGT CCACGATGGT CTCGTGCACA 660 AGCGTTTCCC TGTAGGTCCC ATCGCCGACG TCCCTTACCT CCGAAAGGTC GCCGCCGCTC 720 ACCAGCTACA TCACACAGAC AAGTTCAATG GTGTACCATA TGGACTGTTT CTTGGACCCA 780 AGGAATTGGA AGAAGTTGGA GGAAATGAAG AGTTAGATAA GGAGATTAGT CGGAGAATCA 840 AATCATACAA AAAGGCCTCG GGCTCCGGGT CGAGTTCGAG TTCTTGACTT TAAACAAGTT 900 TTAAATCCCA AATTCTTTTT TTGTCTTCTG TCATTATGAT CATCTTAAGA CGGTCT 956 (2) INFORMATION FOR SEQ ID NO: : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 294 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Ser Phe Ser Ser Ser Ser Thr Asp Phe Arg Leu Arg Leu Pro Lys Ser 1 5 10 15 Leu Ser Gly Phe Ser Pro Ser Leu Arg Phe Lys Arg Phe Ser Val Cys 20 25 30 Tyr Val Val Glu Glu Arg Arg Gin Asn Ser Pro He Glu Asn Asp Glu 35 40 45 Arg Pro Glu Ser Thr Ser Ser Thr Asn Ala He Asp Ala Glu Tyr Leu 50 55 60 Ala Leu Arg Leu Ala Glu Lys Leu Glu Arg Lys Lys Ser Glu Arg Ser 65 70 75 80 Thr Tyr Leu He Ala Ala Met Leu Ser Ser Phe Gly He Thr Ser Met 85 90 95 Ala Val Met Ala Val Tyr Tyr Arg Phe Ser Trp Gin Met Glu Gly Gly 100 105 110 Glu He Ser Met Leu Glu Met Phe Gly Thr Phe Ala Leu Ser Val Gly 115 120 125 Ala Ala Val Gly Met Glu Phe Trp Ala Arg Trp Ala H s Arg Ala Leu 130 135 140 Trp His Ala Ser Leu Trp Met Asn His Glu Ser His His Lys Pro Arg 145 150 155 160 Glu Gly Pro Phe Glu Leu Asn Asp Val Phe Ala He Val Asn Ala Gly 165 170 175 Pro Ala He Gly Leu Leu Ser Tyr Gly Phe Phe Asn Lys Gly Leu Val 180 185 190 Pro Gly Leu Cys Phe Gly Ala Gly Leu Gly He Thr Val Phe Gly He 195 200 205 Ala Tyr Met Phe Val His Asp Gly Leu Val His Lys Arg Phe Pro Val 210 215 220 Gly Pro He Ala Asp Val Pro Tyr Leu Arg Lys Val Ala Ala Ala His 225 230 235 240 Gin Leu His His Thr Asp Lys Phe Asn Gly Val Pro Tyr Gly Leu Phe 245 250 255 Leu Gly Pro Lys Glu Leu Glu Glu Val Gly Gly Asn Glu Glu Leu Asp 260 265 270 Lys Glu He Ser Arg Arg He Lys Ser Tyr Lys Lys Ala Ser Gly Ser 275 280 285 Gly Ser Ser Ser Ser Ser 290 (2) INFORMATION FOR SEQ ID NO: 5 • (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 162 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (Xl) SEQUENCE DESCRIPTION: SEQ ID NO: 5: Met Thr Gin Phe Leu He Val Val Ala Thr Val Leu Val Met Glu Leu 1 5 10 15 Thr Ala Tyr Ser Val His Arg Trp He Met His Gly Pro Leu Gly Trp 20 25 30 Gly Trp His Lys Ser His His Glu Glu His Asp His Ala Leu Glu Lys 35 40 45 Asn Asp Leu Tyr Gly Val Val Phe Ala Val Leu Ala Thr He Leu Phe 50 55 60 Thr Val Gly Ala Tyr Trp Trp Pro Val Leu Trp Trp He Ala Leu Gly 65 70 75 80 Met Thr Val Tyr Gly Leu He Tyr Phe He Leu His Asp Gly Leu Val 85 90 95 His Gin Arg Trp Pro Phe Arg Tyr He Pro Arg Arg Gly Tyr Phe Arg 100 105 110 Arg Leu Tyr Gin Ala His Arg Leu His His Ala Val Glu Gly Arg Asp 115 120 125 His Cys Val Ser Phe Gly Phe He Tyr Ala Pro Pro Val Asp Lys Leu 130 135 140 Lys Gin Asp Leu Lys Arg Ser Gly Val Leu Arg Pro Gin Asp Glu Arg 145 150 155 160 Pro Ser (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 175 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6 : Met Leu Asn Ser Leu He Val He Leu Ser Val He Ala Met Glu Gly 1 5 10 15 He Ala Ala Phe Thr His Arg Tyr He Met His Gly Trp Gly Trp Arg 20 25 30 Trp His Glu Ser His His Thr Pro Arg Lys Gly Val Phe Glu Leu Asn 35 40 45 Asp Leu Phe Ala Val Val Phe Ala Gly Val Ala He Ala Leu He Ala 50 55 60 Val Gly Thr Ala Gly Val Trp Pro Leu Gin Trp He Gly Cys Gly Met 65 70 75 80 Thr Val Tyr Gly Leu Leu Tyr Phe Leu Val His Asp Gly Leu Val His 85 90 95 Gin Arg Trp Pro Phe His Trp He Pro Arg Arg Gly Tyr Leu Lys Arg 100 105 110 Leu Tyr Val Ala His Arg Leu His His Ala Val Arg Gly Arg Glu Gly 115 120 125 Cys Val Ser Phe Gly Phe He Tyr Ala Arg Lys Pro Ala Asp Leu Gin 130 135 140 Ala He Leu Arg Glu Arg His Gly Arg Pro Pro Lys Arg Asp Ala Ala 145 150 155 160 Lys Asp Arg Pro Asp Ala Ala Ser Pro Ser Ser Ser Ser Pro Glu 165 170 175 (2) INFORMATION FOR SEQ ID NO: 7 : (l) SEQUENCE CHARACTERISTICS: (A) LENGTH- 175 ammo acids (C) STRANDEDNESS: Single (D) TOPOLOGY: linear (n) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7 : Met Leu Trp He Trp Asn Ala Leu He Val Phe Val Thr Val He Gly 1 5 10 15 Met Glu Val He Ala Ala Leu Ala His Lys Tyr He Met His Gly Trp 20 25 30 Gly Trp Gly Trp His Leu Ser His His Glu Pro Arg Lys Gly Ala Phe 35 40 45 Glu Val Asn Asp Leu Tyr Ala Val Val Phe Ala Ala Leu Ser He Leu 50 55 60 Leu He Tyr Leu Gly Ser Thr Gly Met Trp Pro Leu Gin Trp He Gly 65 70 75 80 Ala Gly Met Thr Ala Tyr Gly Leu Leu Tyr Phe Met Val His Asp Gly 85 90 95 Leu Val His Gin Arg Trp Pro Phe Arg Tyr He Pro Arg Lys Gly Tyr 100 105 110 Leu Lys Arg Leu Tyr Met Ala His Arg Met His His Ala Val Arg Gly 115 120 125 Lys Glu Gly Cys Val Ser Phe Glv Phe Leu Tvr Ala Pro Pro Leu Ser 130 135 140 Lys Leu Gin Ala Thr Leu Arg Glu Arg His Gly Ala Arg Ala Gly Ala 145 150 155 160 Ala Arg Asp Ala Gin Gly Gly Glu Asp Glu Pro Ala Ser Gly Lys 165 170 175 (2) INFORMATION FOR SEQ ID NO: 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 162 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8 : Met Thr Asn Phe Leu He Val Val Ala Thr Val Leu Val Met Glu Leu 1 5 10 15 Thr Ala Tyr Ser Val His Arg Trp He Met His Gly Pro Leu Gly Trp 20 25 30 Gly Trp His Lys Ser His His Glu Glu His Asp His Ala Leu Glu Lys 35 40 45 Asn Asp Leu Tyr Gly Leu Val Phe Ala Val He Ala Thr Val Leu Phe 50 55 60 Thr Val Gly Trp He Trp Ala Pro Val Leu Trp Trp He Ala Leu Gly 65 70 75 80 Met Thr Val Tyr Gly Leu He Tyr Phe Val Leu His Asp Gly Leu Val 85 90 95 His Trp Arg Trp Pro Phe Arg Tyr He Pro Arg Lys Gly Tyr Ala Arg 100 105 110 Arg Leu Tyr Gin Ala His Arg Leu His His Ala Val Glu Gly Arg Asp 115 120 125 His Cys Val Ser Phe Gly Phe He Tyr Ala Pro Pro Val Asp Lys Leu 130 135 140 Lys Gin Asp Leu Lys Met Ser Gly Val Leu Arg Ala Glu Ala Gin Glu 145 150 155 160 Arg Thr (2) INFORMATION FOR SEQ ID NO: 9 : (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 954 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (il) MOLECULE TYPE. cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: CCACGGGTCC GCCTCCCCGT TTTTTTCCGA TCCGATCTCC GGTGCCGAGG ACTCAGCTGT 60 TTGTTCGCGC TTTCTCAGCC GTCACCATGA CCGATTCTAA CGATGCTGGA ATGGATGCTG 120 TTCAGAGACG ACTCATGTTT GAAGACGAAT GCATTCTCGT TGATGAAAAT AATCGTGTGG 180 TGGGACATGA CACTAAGTAT AACTGTCATC TGATGGAAAA GATTGAAGCT GAGAATTTAC 240 TTCACAGAGC TTTCAGTGTG TTTTTATTCA ACTCCAAGTA TGAGTTGCTT CTCCAGCAAC 300 GGTCAAAAAC AAAGGTTACT TTCCCACTTG TGTGGACAAA CACTTGTTGC AGCCATCCTC 360 TTTACCGTGA ATCCGAGCTT ATTGAAGAGA ATGTGCTTGG TGTAAGAAAT GCCGCACAAA 420 GGAAGCTTTT CGATGAGCTC GGTATTGTAG CAGAAGATGT ACCAGTCGAT GAGTTCACTC 480 CCTTGGGACG CATGCTTTAC AAGGCACCTT CTGATGGGAA ATGGGGAGAG CACGAAGTTG 540 ACTATCTACT CTTCATCGTG CGGGATGTGA AGCTTCAACC AAACCCAGAT GAAGTGGCTG 600 AGATCAAGTA CGTGAGCAGG GAAGAGCTTA AGGAGCTGGT GAAGAAAGCA GATGCTGGCG 660 ATGAAGCTGT GAAACTATCT CCATGGTTCA GATTGGTGGT GGATAATTTC TTGATGAAGT 720 GGTGGGATCA TGTTGAGAAA GGAACTATCA CTGAAGCTGC AGACATGAAA ACCATTCACA 780 AGCTCTGAAC TTTCCATAAG TTTTGGATCT TCCCCTTCCC ATAATAAAAT TAAGAGATGA 840 GACTTTTATT GATTACAGAC AAAACTGGCA ACAAAATCTA TTCCTAGGAT TTTTTTTTGC 900 TTTTTATTTA CTTTTGATTC ATCTCTAGTT TAGTTTTCAT CTTAAAAAAA AAAA 954 (2) INFORMATION FOR SEQ ID NO:10: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 996 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: CACCAATGTC TGTTTCTTCT TTATTTAATC TCCCATTGAT TCGCCTCAGA TCTCTCGCTC 60 TTTCGTCTTC TTTTTCTTCT TTCCGATTTG CCCATCGTCC TCTGTCATCG ATTTCACCGA 120 GAAAGTTACC GAATTTTCGT GCTTTCTCTG GTACCGCTAT GACAGATACT AAAGATGCTG 180 GTATGGATGC TGTTCAGAGA CGTCTCATGT TTGAGGATGA ATGCATTCTT GTTGATGAAA 240 CTGATCGTGT TGTGGGGCAT GTCAGCAAGT ATAATTGTCA TCTGATGGAA AATATTGAAG 300 CCAAGAATTT GCTGCACAGG GCTTTTAGTG TATTTTTATT CAACTCGAAG TATGAGTTGC 360 TTCTCCAGCA AAGGTCAAAC ACAAAGGTTA CGTTCCCTCT AGTGTGGACT AACACTTGTT 420 GCAGCCATCC TCTTTACCGT GAATCAGAGC TTATCCAGGA CAATGCACTA GGTGTGAGGA 480 ATGCTGCACA AAGAAAGCTT CTCGATGAGC TTGGTATTGT AGCTGAAGAT GTACCAGTCG 540 ATGAGTTCAC TCCCTTGGGA CGTATGCTGT ACAAGGCTCC TTCTGATGGC AAATGGGGAG 600 AGCATGAACT TGATTACTTG CTCTTCATCG TGCGAGACGT GAAGGTTCAA CCAAACCCAG 660 ATGAAGTAGC TGAGATCAAG TATGTGAGCC GGGAAGAGCT GAAGGAGCTG GTGAAGAAAG 720 CAGATGCAGG TGAGGAAGGT TTGAAACTGT CACCATGGTT CAGATTGGTG GTGGACAATT 780 TCTTGATGAA GTGGTGGGAT CATGTTGAGA AAGGAACTTT GGTTGAAGCT ATAGACATGA 840 AAACCATCCA CAAACTCTGA ACATCTTTTT TTAAAGTTTT TAAATCAATC AACTTTCTCT 900 TCATCATTTT TATCTTTTCG ATGATAATAA TTTGGGATAT GTGAGACACT TACAAAACTT 960 CCAAGCACCT CAGGCAATAA TAAAGTTTGC GGCCGC 996 (2) INFORMATION FOR SEQ ID NO:11 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1165 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (li) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: CTCGGTAGCT GGCCACAATC GCTATTTGGA ACCTGGCCCG GCGGCAGTCC GATGCCGCGA 60 TGCTTCGTTC GTTGCTCAGA GGCCTCACGC ATATCCCCCG CGTGAACTCC GCCCAGCAGC 120 CCAGCTGTGC ACACGCGCGA CTCCAGTTTA AGCTCAGGAG CATGCAGATG ACGCTCATGC 180 AGCCCAGCAT CTCAGCCAAT CTGTCGCGCG CCGAGGACCG CACAGACCAC ATGAGGGGTG 240 CAAGCACCTG GGCAGGCGGG CAGTCGCAGG ATGAGCTGAT GCTGAAGGAC GAGTGCATCT 300 TGGTGGATGT TGAGGACAAC ATCACAGGCC ATGCCAGCAA GCTGGAGTGT CACAAGTTCC 360 TACCACATCA GCCTGCAGGC CTGCTGCACC GGGCCTTCTC TGTGTTCCTG TTTGACGATC 420 AGGGGCGACT GCTGCTGCAA CAGCGTGCAC GCTCAAAAAT CACCTTCCCA AGTGTGTGGA 480 CGAACACCTG CTGCAGCCAC CCTTTACATG GGCAGACCCC AGATGAGGTG GACCAACTAA 540 GCCAGGTGGC CGACGGAACA GTACCTGGCG CAAAGGCTGC TGCCATCCGC AAGTTGGAGC 600 ACGAGCTGGG GATACCAGCG CACCAGCTGC CGGCAAGCGC GTTTCGCTTC CTCACGCGTT 660 TGCACTACTG TGCCGCGGAC GTGCAGCCAG CTGCGACACA ATCAGCGCTC TGGGGCGAGC 720 ACGAAATGGA CTACATCTTG TTCATCCGGG CCAACGTCAC CTTGGCGCCC AACCCTGACG 780 AGGTGGACGA AGTCAGGTAC GTGACGCAAG AGGAGCTGCG GCAGATGATG CAGCCGGACA 840 ACGGGCTGCA ATGGTCGCCG TGGTTTCGCA TCATCGCCGC GCGCTTCCTT GAGCGTTGGT 900 GGGCTGACCT GGACGCGGCC CTAAACACTG ACAAACACGA GGATTGGGGA ACGGTGCATC 960 ACATCAACGA AGCGTGAAAG CAGAAGCTGC AGGATGTGAA GACACGTCAT GGGGTGGAAT 1020 TGCGTACTTG GCAGCTTCGT ATCTCCTTTT TCTGAGACTG AACCTGCAGT CAGGTCCCAC 1080 AAGGTCAGGT AAAATGGCTC GATAAAATGT ACCGTCACTT TTTGTCGCGT ATACTGAACT 1140 CCAAGAGGTC AAAAAAAAAA AAAAA 1165 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1135 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (il) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: CTCGGTAGCT GGCCACAATC GCTATTTGGA ACCTGGCCCG GCGGCAGTCC GATGCCGCGA 60 TGCTTCGTTC GTTGCTCAGA GGCCTCACGC ATATCCCGCG CGTGAACTCC GCCCAGCAGC 120 CCAGCTGTGC ACACGCGCGA CTCCAGTTTA AGCTCAGGAG CATGCAGCTG CTTTCCGAGG 180 ACCGCACAGA CCACATGAGG GGTGCAAGCA CCTGGGCAGG CGGGCAGTCG CAGGATGAGC 240 TGATGCTGAA GGACGAGTGC ATCTTGGTAG ATGTTGAGGA CAACATCACA GGCCATGCCA 300 GCAAGCTGGA GTGTCACAAG TTCCTACCAC ATCAGCCTGC AGGCCTGCTG CACCGGGCCT 360 TCTCTGTGTT CCTGTTTGAC GATCAGGGGC GACTGCTGCT GCAACAGCGT GCACGCTCAA 420 AAATCACCTT CCCAAGTGTG TGGACGAACA CCTGCTGCAG CCACCCTTTA CATGGGCAGA 480 CCCCAGATGA GGTGGACCAA CTAAGCCAGG TGGCCGACGG AACAGTACCT GGCGCAAAGG 540 CTGCTGCCAT CCGCAAGTTG GAGCACGAGC TGGGGATACC AGCGCACCAG CTGCCGGCAA 600 GCGCGTTTCG CTTCCTCACG CGTTTGCACT ACTGTGCCGC GGACGTGCAG CCAGCTGCGA 660 CACAATCAGC GCTCTGGGGC GAGCACGAAA TGGACTACAT CTTGTTCATC CGGGCCAACG 720 TCACCTTGGC GCCCAACCCT GACGAGGTGG ACGAAGTCAG GTACGTGACG CAAGAGGAGC 780 TGCGGCAGAT GATGCAGCCG GACAACGGGC TTCAATGGTC GCCGTGGTTT CGCATCATCG 840 CCGCGCGCTT CCTTGAGCGT TGGTGGGCTG ACCTGGACGC GGCCCTAAAC ACTGACAAAC 900 ACGAGGATTG GGGAACGGTG CATCACATCA ACGAAGCGTG AAGGCAGAAG CTGCAGGATG 960 TGAAGACACG TCATGGGGTG GAATTGCGTA CTTGGCAGCT TCGTATCTCC TTTTTCTGAG 1020 ACTGAACCTG CAGAGCTAGA GTCAATGGTG CATCATATTC ATCGTCTCTC TTTTGTTTTA 1080 GACTAATCTG TAGCTAGAGT CACTGATGAA TCCTTTACAA CTTTCAAAAA AAAAA 1135 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 960 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: CCAAAAACAA CTCAAATCTC CTCCGTCGCT CTTACTCCGC CATGGGTGAC GACTCCGGCA 60 TGGATGCTGT TCAGCGACGT CTCATGTTTG ACGATGAATG CATTTTGGTG GATGAGTGTG 120 ACAATGTGGT GGGACATGAT ACCAAATACA ATTGTCACTT GATGGAGAAG ATTGAAACAG 180 GTAAAATGCT GCACAGAGCA TTCAGCGTTT TTCTATTCAA TTCAAAATAC GAGTTACTTC 240 TTCAGCAACG GTCTGCAACC AAGGTGACAT TTCCTTTAGT ATGGACCAAC ACCTGTTGCA 300 GCCATCCACT CTACAGAGAA TCCGAGCTTG TTCCCGAAAC GCCTGAGAGA ATGCTGCACA 360 GAGGANNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 420 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 480 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 540 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 600 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 660 NNNNNNNNNN NNNNNNNNNN TCATGTGCAA AAGGGTACAC TCACTGAATG CAATTTGATA 720 TGAAAACCAT ACACAAGCTG ATATAGAAAC ACACCCTCAA CCGAAAAGCA AGCCTAATAA 780 TTCGGGTTGG GTCGGGTCTA CCATCAATTG TTTTTTTCTT TTAACAACTT TTAATCTCTA 840 TTTGAGCATG TTGATTCTTG TCTTTTGTGT GTAAGATTTT GGGTTTCGTT TCAGTTGTAA 900 TAATGAACCA TTGATGGTTT GCAATTTCAA GTTCCTATCG ACATGTAGTG ATCTAAAAAA 960 (2) INFORMATION FOR SEQ ID NO:14 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 305 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: Met Leu Arg Ser Leu Leu Arg Gly Leu Thr His He Pro Arg Val Asn 1 5 10 15 Ser Ala Gin Gin Pro Ser Cys Ala His Ala Arg Leu Gin Phe Lys Leu 20 25 30 Arg Ser Met Gin Met Thr Leu Met Gin Pro Ser He Ser Ala Asn Leu 35 40 45 Ser Arg Ala Glu Asp Arg Thr Asp His Met Arg Gly Ala Ser Thr Trp 50 55 60 Ala Gly Gly Gin Ser Gin Asp Glu Leu Met Leu Lys Asp Glu Cys He 65 70 75 80 Leu Val Asp Val Glu Asp Asn He Thr Gly His Ala Ser Lys Leu Glu 85 90 95 Cys His Lys Phe Leu Pro His Gin Pro Ala Gly Leu Leu His Arg Ala 100 105 110 Phe Ser Val Phe Leu Phe Asp Asp Gin Gly Arg Leu Leu Leu Gin Gin 115 120 125 Arg Ala Arg Ser Lys He Thr Phe Pro Ser Val Trp Thr Asn Thr Cys 130 135 140 Cys Ser His Pro Leu His Gly Gin Thr Pro Asp Glu Val Asp Gin Leu 145 150 155 160 Ser Gin Val Ala Asp Gly Thr Val Pro Gly Ala Lys Ala Ala Ala He 165 170 175 Arg Lys Leu Glu His Glu Leu Gly He Pro Ala His Gin Leu Pro Ala 180 185 190 Ser Ala Phe Arg Phe Leu Thr Arg Leu His Tyr Cys Ala Ala Asp Val 195 200 205 Gin Pro Ala Ala Thr Gin Ser Ala Leu Trp Gly Glu His Glu Met Asp 210 215 220 Tyr He Leu Phe He Arg Ala Asn Val Thr Leu Ala Pro Asn Pro Asp 225 230 235 240 Glu Val Asp Glu Val Arg Tyr Val Thr Gin Glu Glu Leu Arg Gin Met 245 250 255 Met Gin Pro Asp Asn Gly Leu Gin Trp Ser Pro Trp Phe Arg He He 260 265 270 Ala Ala Arg Phe Leu Glu Arg Trp Trp Ala Asp Leu Asp Ala Ala Leu 275 280 285 Asn Thr Asp Lys His Glu Asp Trp Gly Thr Val His His He Asn Glu 290 295 300 Ala 305 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 293 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: Met Leu Arg Ser Leu Leu Arg Gly Leu Thr His He Pro Arg Val Asn 1 5 10 15 Ser Ala Gin Gin Pro Ser Cys Ala His Ala Arg Leu Gin Phe Lys Leu 20 25 30 Arg Ser Met Gin Leu Leu Ser Glu Asp Arg Thr Asp His Met Arg Gly 35 40 45 Ala Ser Thr Trp Ala Gly Gly Gin Ser Gin Asp Glu Leu Met Leu Lys 50 55 60 Asp Glu Cys He Leu Val Asp Val Glu Asp Asn He Thr Gly His Ala 65 70 75 80 Ser Lys Leu Glu Cys His Lys Phe Leu Pro His Gin Pro Ala Gly Leu 85 90 95 Leu His Arg Ala Phe Ser Val Phe Leu Phe Asp Asp Gin Gly Arg Leu 100 105 110 Leu Leu Gin Gin Arg Ala Arg Ser Lys He Thr Phe Pro Ser Val Trp 115 120 125 Thr Asn Thr Cys Cys Ser His Pro Leu His Gly Gin Thr Pro Asp Glu 130 135 140 Val Asp Gin Leu Ser Gin Val Ala Asp Gly Thr Val Pro Gly Ala Lys 145 150 155 160 Ala Ala Ala He Arg Lys Leu Glu His Glu Leu Gly He Pro Ala His 165 170 175 Gin Leu Pro Ala Ser Ala Phe Arg Phe Leu Thr Arg Leu His Tyr Cys 180 185 190 Ala Ala Asp Val Gin Pro Ala Ala Thr Gin Ser Ala Leu Trp Gly Glu 195 200 205 His Glu Met Asp Tyr He Leu Phe He Arg Ala Asn Val Thr Leu Ala 210 215 220 Pro Asn Pro Asp Glu Val Asp Glu Val Arg Tyr Val Thr Gin Glu Glu 225 230 235 240 Leu Arg Gin Met Met Gin Pro Asp Asn Gly Leu Gin Trp Ser Pro Trp 245 250 255 Phe Arg He He Ala Ala Arg Phe Leu Glu Arg Trp Trp Ala Asp Leu 260 265 270 Asp Ala Ala Leu Asn Thr Asp Lys His Glu Asp Trp Gly Thr Val His 275 280 285 His He Asn Glu Ala 290 (2) INFORMATION FOR SEQ ID NO: 16: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 ammo acids (B) TYPE- amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION- SEQ ID NO: 16: Met Ser Val Ser Ser Leu Phe Asn Leu Pro Leu He Arg Leu Arg Ser 1 5 10 15 Leu Ala Leu Ser Ser Ser Phe Ser Ser Phe Arg Phe Ala His Arg Pro 20 25 30 Leu Ser Ser He Ser Pro Arg Lys Leu Pro Asn Phe Arg Ala Phe Ser 35 40 45 Gly Thr Ala Met Thr Asp Thr Lys Asp Ala Gly Met Asp Ala Val Gin 50 55 60 Arg Arg Leu Met Phe Glu Asp Glu Cys He Leu Val Asp Glu Thr Asp 65 70 75 80 Arg Val Val Gly His Val Ser Lys Tyr Asn Cys His Leu Met Glu Asn 85 90 95 He Glu Ala Lys Asn Leu Leu His Arg Ala Phe Ser Val Phe Leu Phe 100 105 110 Asn Ser Lys Tyr Glu Leu Leu Leu Gin Gin Arg Ser Asn Thr Lys Val 115 120 125 Thr Phe Pro Leu Val Trp Thr Asn Thr Cys Cys Ser His Pro Leu Tyr 130 135 140 Arg Glu Ser Glu Leu He Gin Asp Asn Ala Leu Gly Val Arg Asn Ala 145 150 155 160 Ala Gin Arg Lys Leu Leu Asp Glu Leu Gly He Val Ala Glu Asp Val 165 170 175 Pro Val Asp Glu Phe Thr Pro Leu Gly Arg Met Leu Tyr Lys Ala Pro 180 185 190 Ser Asp Gly Lys Trp Gly Glu His Glu Leu Asp Tyr Leu Leu Phe He 195 200 205 Val Arg Asp Val Lys Val Gin Pro Asn Pro Asp Glu Val Ala Glu He 210 215 220 Lys Tyr Val Ser Arg Glu Glu Leu Lys Glu Leu Val Lys Lys Ala Asp 225 230 235 240 Ala Gly Glu Glu Gly Leu Lys Leu Ser Pro Trp Phe Arg Leu Val Val 245 250 255 Asp Asn Phe Leu Met Lys Trp Trp Asp His Val Glu Lys Gly Thr Leu 260 265 270 val Glu Ala He Asp Met Lys Thr He His Lys Leu 275 280 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 287 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: Met Ser Ser Ser Met Leu Asn Phe Thr Ala Ser Arg He Val Ser Leu 1 5 10 15 Pro Leu Leu Ser Ser Pro Pro Ser Arg Val His Leu Pro Leu Cys Phe 20 25 30 Phe Ser Pro He Ser Leu Thr Gin Arg Phe Ser Ala Lys Leu Thr Phe 35 40 45 Ser Ser Gin Ala Thr Thr Met Gly Glu Val Val Asp Ala Gly Met Asp 50 55 60 Ala Val Gin Arg Arg Leu Met Phe Glu Asp Glu Cys He Leu Val Asp 65 70 75 80 Glu Asn Asp Lys Val Val Gly His Glu Ser Lys Tyr Asn Cys His Leu 85 . 90 95 Met Glu Lys He Glu Ser Glu Asn Leu Leu His Arg Ala Phe Ser Val 100 105 110 Phe Leu Phe Asn Ser Lys Tyr Glu Leu Leu Leu Gin Gin Arg Ser Ala 115 120 125 Thr Lys Val Thr Phe Pro Leu Val Trp Thr Asn Thr Cys Cys Ser His 130 135 140 Pro Leu Tyr Arg Glu Ser Glu Leu He Asp Glu Asn Cys Leu Gly Val 145 150 155 160 Arg Asn Ala Ala Gin Arg Lys Leu Leu Asp Glu Leu Gly He Pro Ala 165 170 175 Glu Asp Leu Pro Val Asp Gin Phe He Pro Leu Ser Arg He Leu Tyr 180 185 190 Lys Ala Pro Ser Asp Gly Lys Trp Gly Glu His Glu Leu Asp Tyr Leu 195 200 205 Leu Phe He He Arg Asp Val Asn Leu Asp Pro Asn Pro Asp Glu Val 210 215 220 Ala Glu Val Lys Tyr Met Asn Arg Asp Asp Leu Lys Glu Leu Leu Arg 225 230 235 240 Lys Ala Asp Ala Glu Glu Glu Gly Val Lys Leu Ser Pro Trp Phe Arg 245 250 255 Leu Val Val Asp Asn Phe Leu Phe Lys Trp Trp Asp His Val Glu Lys 260 265 270 Gly Ser Leu Lys Asp Ala Ala Asp Met Lys Thr He His Lys Leu 275 280 285 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 261 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein ( i) SEQUENCE DESCRIPTION: SEQ ID NO: 18: Thr Gly Pro Pro Pro Arg Phe Phe Pro He Arg Ser Pro Val Pro Arg 1 5 10 15 Thr Gin Leu Phe Val Arg Ala Phe Ser Ala Val Thr Met Thr Asp Ser 20 25 30 Asn Asp Ala Gly Met Asp Ala Val Gin Arg Arg Leu Met Phe Glu Asp 35 40 45 Glu Cys He Leu Val Asp Glu Asn Asn Arg Val Val Gly His Asp Thr 50 55 60 Lys Tyr Asn Cys His Leu Met Glu Lys He Glu Ala Glu Asn Leu Leu 65 70 75 80 His Arg Ala Phe Ser Val Phe Leu Phe Asn Ser Lys Tyr Glu Leu Leu 85 90 95 Leu Gin Gin Arg Ser Lys Thr Lys Val Thr Phe Pro Leu Val Trp Thr 100 105 110 Asn Thr Cys Cys Ser His Pro Leu Tyr Arg Glu Ser Glu Leu He Glu 115 120 125 Glu Asn Val Leu Gly Val Arg Asn Ala Ala Gin Arg Lys Leu Phe Asp 130 135 140 Glu Leu Gly He Val Ala Glu Asp Val Pro Val Asp Glu Phe Thr Pro 145 150 155 160 Leu Gly Arg Met Leu Tyr Lys Ala Pro Ser Asp Gly Lys Trp Gly Glu 165 170 175 His Glu Val Asp Tyr Leu Leu Phe He Val Arg Asp Val Lys Leu Gin 180 185 190 Pro Asn Pro Asp Glu Val Ala Glu He Lys Tyr Val Ser Arg Glu Glu 195 200 205 Leu Lys Glu Leu Val Lys Lys Ala Asp Ala Gly Asp Glu Ala Val Lys 210 215 220 Leu Ser Pro Trp Phe Arg Leu Val Val Asp Asn Phe Leu Met Lys Trp 225 230 235 240 Trp Asp His Val Glu Lys Gly Thr He Thr Glu Ala Ala Asp Met Lys 245 250 255 Thr He His Lys Leu 260 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 288 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: Met Thr Ala Asp Asn Asn Ser Met Pro His Gly Ala Val Ser Ser Tyr 1 5 10 15 Ala Lys Leu Val Gin Asn Gin Thr Pro Glu Asp He Leu Glu Glu Phe 20 25 30 Pro Glu He He Pro Leu Gin Gin Arg Pro Asn Thr Arg Ser Ser Glu 35 40 45 Thr Ser Asn Asp Glu Ser Gly Glu Thr Cys Phe Ser Gly His Asp Glu 50 55 60 Glu Gin He Lys Leu Met Asn Glu Asn Cys He Val Leu Asp Trp Asp 65 70 75 80 Asp Asn Ala He Gly Ala Gly Thr Lys Lys Val Cys His Leu Met Glu 85 90 95 Asn He Glu Lys Gly Leu Leu His Arg Ala Phe Ser Val Phe He Phe 100 105 110 Asn Glu Gin Gly Glu Leu Leu Leu Gin Gin Arg Ala Thr Glu Lys He 115 120 125 Thr Phe Pro Asp Leu Trp Thr Asn Thr Cys Cys Ser His Pro Leu Cys 130 135 140 He Asp Asp Glu Leu Gly Leu Lys Gly Lys Leu Asp Asp Lys He Lys 145 150 155 160 Gly Ala He Thr Ala Ala Val Arg Lys Leu Asp His Glu Leu Gly He 165 170 175 Pro Glu Asp Glu Thr Lys Thr Arg Gly Lys Phe His Phe Leu Asn Arg 180 185 190 He His Tyr Met Ala Pro Ser Asn Glu Pro Trp Gly Glu His Glu He 195 200 205 Asp Tyr He Leu Phe Tyr Lys He Asn Ala Lys Glu Asn Leu Thr Val 210 215 220 Asn Pro Asn Val Asn Glu Val Arg Asp Phe Lys Trp Val Ser Pro Asn 225 230 235 240 Asp Leu Lys Thr Met Phe Ala Asp Pro Ser Tyr Lys Phe Thr Pro Trp 245 250 255 Phe Lys He He Cys Glu Asn Tyr Leu Phe Asn Trp Trp Glu Gin Leu 260 265 270 Asp Asp Leu Ser Glu Val Glu Asn Asp Arg Gin He His Arg Met Leu 275 280 285 (2) INFORMATION FOR SEQ ID NO-20- (l) SEQUENCE CHARACTERISTICS: (A) LENGTH 456 ammo acids (C) STRANDEDNESS- single (D) TOPOLOGY linear (ii) MOLECULE TYPE- protein (xi) SEQUENCE DESCRIPTION SEQ ID NO.20 Met Asp Thr Leu Leu Lys Thr Pro Asn Leu Glu Phe Leu Pro His Gly 1 5 10 15 Phe Val Lys Ser Phe Ser Lys Phe Gly Lys Cys Glu Gly Val Cys Val 20 25 30 Lys Ser Ser Ala Leu Leu Glu Leu Val Pro Glu Thr Lys Lys Glu Asn 35 40 45 Leu Asp Phe Glu Leu Pro Met Tyr Asp Pro Ser Lys Gly Val Val Asp 50 55 60 Leu Ala Val Val Gly Gly Gly Pro Ala Gly Leu Ala Val Ala Gin Gin 65 70 75 80 Val Ser Glu Ala Gly Leu Ser Val Cys Ser He Asp Pro Pro Lys Leu 85 90 95 He Trp Pro Asn Asn Tyr Gly Val Trp Val Asp Glu Phe Glu Ala Met 100 105 110 Asp Leu Leu Asp Cys Leu Asp Ala Thr Trp Ser Gly Ala Val Tyr He 115 120 125 Asp Asp Thr Lys Asp Leu Arg Pro Tyr Gly Arg Val Asn Arg Lys Gin 130 135 140 Leu Lys Ser Lys Met Met Gin Lys Cys He Asn Gly Val Lys Phe His 145 150 155 160 Gin Ala Lys Val He Lys Val He His Glu Glu Lys Ser Met Leu He 165 170 175 Cys Asn Asp Gly Thr He Gin Ala Thr Val Val Leu Asp Ala Thr Gly 180 185 190 Phe Ser Arg Leu Val Gin Tyr Asp Lys Pro Tyr Asn Pro Gly Tyr Gin 195 200 205 Val Ala Tyr Gly He Leu Ala Glu Val Glu Glu His Pro Phe Asp Lys 210 215 220 Met Val Phe Met Asp Trp Arg Asp Ser His Leu Asn Asn Glu Leu Lys 225 230 235 240 Glu Arg Asn Ser He Pro Thr Phe Leu Tyr Ala Met Pro Phe Ser Ser 245 250 255 Asn Arg He Phe Leu Glu Glu Thr Ser Leu Val Ala Arg Pro Gly Leu 260 265 270 Arg Met Asp Asp He Gin Glu Arg Met Val Ala Arg Leu His Leu Gly 275 280 285 He Lys Val Lys Ser He Glu Glu Asp Glu His Cys Val He Pro Met 290 295 300 Gly Gly Pro Leu Pro Val Leu Pro Gin Arg Val Val Gly He Gly Gly 305 310 315 320 Thr Ala Gly Met Val His Pro Ser Thr Gly Tyr Met Val Ala Arg Thr 325 330 335 Leu Ala Ala Ala Pro Val Val Ala Asn Ala He He Tyr Leu Gly Ser 340 345 350 Glu Ser Ser Gly Glu Leu Ser Ala Glu Val Trp Lys Asp Leu Trp Pro 355 360 365 He Glu Arg Arg Arg Gin Arg Glu Phe Phe Cys Phe Gly Met Asp He 370 375 380 Leu Leu Lys Leu Asp Leu Pro Ala Thr Arg Arg Phe Phe Asp Ala Phe 385 390 395 400 Phe Asp Leu Glu Pro Arg Tyr Trp His Gly Phe Leu Ser Ser Arg Leu 405 410 415 Phe Leu Pro Glu Leu He Val Phe Gly Leu Ser Leu Phe Ser His Ala 420 425 430 Ser Asn Thr Ser Arg Glu He Met Thr Lys Gly Thr Pro Leu Val Met 435 440 445 He Asn Asn Leu Leu Gin Asp Glu 450 455 (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 524 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: Met Glu Cys Val Gly Ala Arg Asn Phe Ala Ala Met Ala Val Ser Thr 1 5 10 15 Phe Pro Ser Trp Ser Cys Arg Arg Lys Phe Pro Val Val Lys Arg Tyr 20 25 30 Ser Tyr Arg Asn He Arg Phe Gly Leu Cys Ser Val Arg Ala Ser Gly 35 40 45 Gly Gly Ser Ser Gly Ser Glu Ser Cys Val Ala Val Arg Glu Asp Phe 50 55 60 Ala Asp Glu Glu Asp Phe Val Lys Ala Gly Gly Ser Glu He Leu Phe 65 70 75 80 Val Gin Met Gin Gin Asn Lys Asp Met Asp Glu Gin Ser Lys Leu Val 85 90 95 Asp Lys Leu Pro Pro He Ser He Gly Asp Gly Ala Leu Asp His Val 100 105 110 Val He Gly Cys Gly Pro Ala Gly Leu Ala Leu Ala Ala Glu Ser Ala 115 120 125 Lys Leu Gly Leu Lys Val Gly Leu He Gly Pro Asp Leu Pro Phe Thr 130 135 140 Asn Asn Tyr Gly Val Trp Glu Asp Glu Phe Asn Asp Leu Gly Leu Gin 145 150 155 160 Lys Cys He Glu His Val Trp Arg Glu Thr He Val Tyr Leu Asp Asp 165 170 175 Asp Lys Pro He Thr He Gly Arg Ala Tyr Gly Arg Val Ser Arg Arg 180 185 190 Leu Leu His Glu Glu Leu Leu Arg Arg Cys Val Glu Ser Gly Val Ser 195 200 205 Tyr Leu Ser Ser Lys Val Asp Ser He Thr Glu Ala Ser Asp Gly Leu 210 215 220 Arg Leu Val Ala Cys Asp Asp Asn Asn Val He Pro Cys Arg Leu Ala 225 230 235 240 Thr Val Ala Ser Gly Ala Ala Ser Gly Lys Leu Leu Gin Tyr Glu Val 245 250 255 Gly Gly Pro Arg Val Cys Val Gin Thr Ala Tyr Gly Val Glu Val Glu 260 265 270 Val Glu Asn Ser Pro Tyr Asp Pro Asp Gin Met Val Phe Met Asp Tyr 275 280 285 Arg Asp Tyr Thr Asn Glu Lys Val Arg Ser Leu Glu Ala Glu Tyr Pro 290 295 300 Thr Phe Leu Tyr Ala Met Pro Met Thr Lys Ser Arg Leu Phe Phe Glu 305 310 315 320 Glu Thr Cys Leu Ala Ser Lys Asp Val Met Pro Phe Asp Leu Leu Lys 325 330 335 Thr Lys Leu Met Leu Arg Leu Asp Thr Leu Gly He Arg He Leu Lys 340 345 350 Thr Tyr Glu Glu Glu Trp Ser Tyr He Pro Val Gly Gly Ser Leu Pro 355 360 365 57/1 Asn Thr Glu Gin Lys Asn Leu Ala Phe Gly Ala Ala Ala Ser Met Val 370 375 380 His Pro Ala Thr Gly Tyr Ser Val Val Arg Ser Leu Ser Glu Ala Pro 385 390 395 400 Lys Tyr Ala Ser Val He Ala Glu He Leu Arg Glu Glu Thr Thr Lys 405 410 415 Gin He Asn Ser Asn He Ser Arg Gin Ala Trp Asp Thr Leu Trp Pro 420 425 430 Pro Glu Arg Lys Arg Gin Arg Ala Phe Phe Leu Phe Gly Leu Ala Leu 435 440 445 He Val Gin Phe Asp Thr Glu Gly He Arg Ser Phe Phe Arg Thr Phe 450 455 460 Phe Arg Leu Pro Lys Trp Met Trp Gin Gly Phe Leu Gly Ser Thr Leu 465 470 475 480 Thr Ser Gly Asp Leu Val Leu Phe Ala Leu Tyr Met Phe Val He Ser 485 490 495 Pro Asn Asn Leu Arg Lys Gly Leu He Asn His Leu He Ser Asp Pro 500 505 510 Thr Gly Ala Thr Met He Lys Thr Tyr Leu Lys Val 515 520

Claims: 58 Claims 1. An isolated eukaryotic enzyme having the amino acid sequence of SEQ ID NO: 2, 4, 14, 15, 16 or 18. 2. An isolated eukaryotic enzyme of Claim 1 which is a e cyclase enzyme having the amino acid sequence of SEQ ID NO: 2. 3. An isolated DNA sequence comprising a gene encoding the eukaryotic e cyclase of Claim 2. 4. The isolated DNA sequence according to Claim 3, having the nucleic acid sequence of SEQ ID NO: 1. 5. An expression vector comprising the DNA sequence of Claim 3. 6. The expression vector according to Claim 5 which is pATeps deposited with the American Type Culture Collection on March 4, 1996 under accession number 98005. 7. A host containing the expression vector of Claim 5. 8. A host containing the expression vector of Claim 6. 9. An isolated eukaryotic enzyme of Claim 1, which is an isopentenyl isomerase (IPP) enzyme having the amino acid sequence of SEQ ID NOS: 14, 15, 16 or 18. 10. An isolated DNA sequence comprising a gene encoding the IPP enzyme of Claim 9. 11. The isolated DNA sequence of Claim 10, having the nucleic acid sequence of SEQ ID NOS: 9, 10, 11 or 12. 12. An expression vector comprising the DNA sequence of Claim 10. - 59 - 13. The expression vector of Claim 11 which is pHP05, pMDPl, pATDP7 or pHP04, deposited with the American Type Culture Collection on March 4, 1996 under accession Nos. 98000, 98001, 98002 or 98004. 14. A host containing the expression vector of Claim 12. 15. The isolated eukaryotic enzyme of Claim 1, which is jβ-carotene hydroxylase enzyme having the amino acid sequence of SEQ ID NO: 4. 16. An isolated DNA sequence comprising a gene encoding the β-carotene hydroxylase enzyme of Claim 15. 17. The isolated DNA sequence according to Claim 16, having the nucleic acid sequence of SEQ ID NO: 3. 18. An expression vector comprising the DNA sequence of Claim 16. 19. The expression vector according to Claim 18 which is pATOHB deposited with the American Type Culture Collection on March 4, 1996 under accession number 98003. 20. A host containing the expression vector of Claim 18. 21. A host containing the expression vector of Claim 19. 22. A DNA sequence which, when incorporated into a prokaryotic host, results in the expression of an eukaryotic carotenoid biosynthetic enzyme, wherein said DNA sequence comprises a truncated portion of the naturally occurring DNA sequence encoding said eukaryotic carotenoid biosynthetic enzyme, wherein said - 60 - truncated portion comprises said natural sequence minus at least one codon at the 5' terminus. 23. The DNA sequence of Claim 22, wherein said eukayotic carotenoid biosynthetic enzyme is /3-carotene hydroxylase. 24. The DNA sequence of Claim 23, which is a Balll - 3' end exofragment of SEQ ID NO: 3 fused to a 5' ATG start codon. 25. A method for screening for eukaryotic genes involved in carotenoid biosynthesis, metabolism or degradation comprising the steps of: engineering of a prokaryotic host which accumulates a carotenoid or carotenoid precursor or which is deficient in an enzyme of the carotenoid pathway; transforming said host with DNA which may contain an eukaryotic carotenoid biosynthetic gene; culturing said transformed host to obtain colonies; and screening for colonies exhibiting a different visual appearance than colonies of the untransfoπned host. 26. The method of Claim 25, wherein said prokaryotic host is E. coli . 27. A method for producing a carotenoid, comprising the steps of: transforming a host with DNA which comprises a eukaryotic carotenoid biosynthetic gene; culturing said host for a time sufficient for said host to produce said carotenoid; and collecting said carotenoid from the host. - 61 - 28. The method of Claim 26, wherein said DNA further comprises a isopentyl pyrophospate isomerase gene. 29. A method for inhibiting carotenoid biosynthesis in a host, comprising the steps of: transforming said host with antisense DNA to a eukaryotic carotenoid biosynthesis gene; and culturing said host. 30. A method for increasing production of a secondary metabolite of isopentyl pyrophosphate (IPP) by a host, comprising the steps of: transforming said host with DNA that comprises an isopentyl pyrophosphate isomerase gene; and culturing said host for a time sufficient to produce said secondary metabolite; and recovering said secondary metabolite from said host. 31. The method of Claim 30, wherein said secondary metabolite is a carotenoid. 32. A method for screening for secondary metabolites, comprising: engineering a host which accumulates a secondary metabolite or secondary metabolite precursor of isopentyl pyrophosphate (IPP) ; and transforming said host with DNA that may contain an IPP isomerase gene; and culturing said host for a time sufficient to accumulate said secondary metabolite or precursor; and screening for said secondary metabolite or precursor.

Inventors: CUNNINGHAM FRANCIS X JR, SUN ZAIREN, CUNNINGHAM, FRANCIS, X., JR., SUN, ZAIREN
Applicants: UNIV MARYLAND, UNIVERSITY OF MARYLAND COLLEGE PARK
Application year: 1997
Main classification: C12N1
IPC codes: C12N1, C12N9, C12N15, C12P23, C12Q1, C12R1